Discontinuation of long-acting beta-agonist therapy in patients whose asthma is well controlled is associated with a worsening of symptom control and quality of life, a systematic review suggested.
SILVER SPRING, Md. -- Generic forms of the popular asthma drug montelukast sodium (SingulaIr) produced by 10 manufacturers have won FDA approval, the agency announced.